PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'From the Department of Ophthalmology, Bingham University, Karu/Jos, Nassarawa/Plateau state, Nigeria.\', \'Department of Surgery, College of Medicine and Lagos University Teaching Hospital, Lagos, Nigeria.\', \'Division of Hypertension and Clinical pharmacology, Keck Department of Medicine, Baylor College of Medicine Houston Texas, TX 77030, USA.\', \'Department of Surgery, Lagos University Teaching Hospital, Lagos, Nigeria.\', \'Department of Medicine, Lagos University Teaching Hospital, Lagos, Nigeria.\', \'Department of Medicine, Faculty of Clinical Sciences, College of Medicine/Lagos University Teaching Hospital, Lagos, Nigeria.\', \'Central Research Laboratory/Department of Medical Microbiology and Parasitology, Centre for Human and Zoonotic Virology, College of Medicine, University of Lagos, Lagos, Nigeria.\', \'Department of Oral and Maxillofacial Surgery, College of Medicine, University of Lagos, Lagos, Nigeria.\']
?:citedBy
  • -1
?:creator
?:doi
  • 10.1093/qjmed/hcab035
?:doi
?:hasPublicationType
?:journal
  • QJM : monthly journal of the Association of Physicians
is ?:pmid of
?:pmid
?:pmid
  • 33599247
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • -1.0
?:rankingScore_hIndex
  • -1
?:title
  • Ivermectin shows clinical benefits in mild to moderate COVID19: a randomized controlled double-blind, dose-response study in Lagos.
?:type
?:year
  • 2022

Metadata

Anon_0  
expand all